Publikation:

Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD+ metabolism

Lade...
Vorschaubild

Dateien

Bruell_2-1oj23hpgyshkn2.pdf
Bruell_2-1oj23hpgyshkn2.pdfGröße: 4.42 MBDownloads: 3

Datum

2025

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

ArXiv-ID

Internationale Patentnummer

Link zur Lizenz

Angaben zur Forschungsförderung

Deutsche Forschungsgemeinschaft (DFG): TRR353
Institutionen der Bundesrepublik Deutschland: 161L0243B
Institutionen der Bundesrepublik Deutschland: 016LW0146K
European Union (EU): 964537
European Union (EU): 964518
European Union (EU): 101057014

Projekt

Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Cell Death & Disease. Springer. 2025, 16(1), 24. eISSN 2041-4889. Verfügbar unter: doi: 10.1038/s41419-024-07326-w

Zusammenfassung

Neurite degeneration (ND) precedes cell death in many neurodegenerative diseases. However, it remains unclear how this compartmentalized cell death process is orchestrated in the central nervous system (CNS). The establishment of a CNS axotomy model (using modified 3D LUHMES cultures) allowed us to study metabolic control of ND in human midbrain-derived neurons without the use of toxicants or other direct disturbance of cellular metabolism. Axotomy lead to a loss of the NAD+ synthesis enzyme NMNAT2 within 2 h and a depletion of NAD+ within 4-6 h. This process appeared specific, as isolated neurites maintained ATP levels and a coupled mitochondrial respiration for at least 6 h. In the peripheral nervous system (PNS) many studies observed that NAD+ metabolism, in particular by the NADase SARM1, plays a major role in the ND occurring after axotomy. Since neither ferroptosis nor necroptosis, nor caspase-dependent apoptosis seemed to be involved in neurite loss, we investigated SARM1 as potential executioner (or controller). Knock-down or expression of a dominant-negative isoform of SARM1 indeed drastically delayed ND. Various modifications of NAD+ metabolism known to modulate SARM1 activity showed the corresponding effects on ND. Moreover, supplementation with NAD+ attenuated ND. As a third approach to investigate the role of altered NAD+ metabolism, we made use of the WLD(s) protein, which has been found in a mutant mouse to inhibit Wallerian degeneration of axons. This protein, which has a stable NMNAT activity, and thus can buffer the loss of NMNAT2, protected the neurites by stabilizing neurite NAD+ levels. Thus CNS-type ND was tightly linked to neurite metabolism in multiple experimental setups. Based on this knowledge, several new strategies for treating neurodegenerative diseases can be envisaged.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690BRÜLL, Markus, Selina MULTRUS, Michael SCHÄFER, Ivana CELARDO, Christiaan KARREMAN, Marcel LEIST, 2025. Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD+ metabolism. In: Cell Death & Disease. Springer. 2025, 16(1), 24. eISSN 2041-4889. Verfügbar unter: doi: 10.1038/s41419-024-07326-w
BibTex
@article{Brull2025-01-17Progr-72010,
  title={Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD<sup>+</sup> metabolism},
  year={2025},
  doi={10.1038/s41419-024-07326-w},
  number={1},
  volume={16},
  journal={Cell Death & Disease},
  author={Brüll, Markus and Multrus, Selina and Schäfer, Michael and Celardo, Ivana and Karreman, Christiaan and Leist, Marcel},
  note={Article Number: 24}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/72010">
    <dc:creator>Leist, Marcel</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>2025-01-17</dcterms:issued>
    <dc:contributor>Karreman, Christiaan</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-01-22T11:50:22Z</dc:date>
    <dc:creator>Karreman, Christiaan</dc:creator>
    <dcterms:abstract>Neurite degeneration (ND) precedes cell death in many neurodegenerative diseases. However, it remains unclear how this compartmentalized cell death process is orchestrated in the central nervous system (CNS). The establishment of a CNS axotomy model (using modified 3D LUHMES cultures) allowed us to study metabolic control of ND in human midbrain-derived neurons without the use of toxicants or other direct disturbance of cellular metabolism. Axotomy lead to a loss of the NAD&lt;sup&gt;+&lt;/sup&gt; synthesis enzyme NMNAT2 within 2 h and a depletion of NAD&lt;sup&gt;+&lt;/sup&gt; within 4-6 h. This process appeared specific, as isolated neurites maintained ATP levels and a coupled mitochondrial respiration for at least 6 h. In the peripheral nervous system (PNS) many studies observed that NAD&lt;sup&gt;+&lt;/sup&gt; metabolism, in particular by the NADase SARM1, plays a major role in the ND occurring after axotomy. Since neither ferroptosis nor necroptosis, nor caspase-dependent apoptosis seemed to be involved in neurite loss, we investigated SARM1 as potential executioner (or controller). Knock-down or expression of a dominant-negative isoform of SARM1 indeed drastically delayed ND. Various modifications of NAD&lt;sup&gt;+&lt;/sup&gt; metabolism known to modulate SARM1 activity showed the corresponding effects on ND. Moreover, supplementation with NAD&lt;sup&gt;+&lt;/sup&gt; attenuated ND. As a third approach to investigate the role of altered NAD&lt;sup&gt;+&lt;/sup&gt; metabolism, we made use of the WLD(s) protein, which has been found in a mutant mouse to inhibit Wallerian degeneration of axons. This protein, which has a stable NMNAT activity, and thus can buffer the loss of NMNAT2, protected the neurites by stabilizing neurite NAD&lt;sup&gt;+&lt;/sup&gt; levels. Thus CNS-type ND was tightly linked to neurite metabolism in multiple experimental setups. Based on this knowledge, several new strategies for treating neurodegenerative diseases can be envisaged.</dcterms:abstract>
    <dc:contributor>Brüll, Markus</dc:contributor>
    <dcterms:title>Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD&lt;sup&gt;+&lt;/sup&gt; metabolism</dcterms:title>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:language>eng</dc:language>
    <dc:contributor>Celardo, Ivana</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/72010/4/Bruell_2-1oj23hpgyshkn2.pdf"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-01-22T11:50:22Z</dcterms:available>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:creator>Schäfer, Michael</dc:creator>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Multrus, Selina</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/72010"/>
    <dc:creator>Celardo, Ivana</dc:creator>
    <dc:creator>Brüll, Markus</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/72010/4/Bruell_2-1oj23hpgyshkn2.pdf"/>
    <dc:contributor>Schäfer, Michael</dc:contributor>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:creator>Multrus, Selina</dc:creator>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen